Editorial Board
Dr. Ladan Teimoori-Toolabi PhD
Molecular Medicine Department, Pasteur Institute of Iran · Iran, Islamic Republic of
Editorial leadership for Journal of Cancer Genetics And Biomarkers ISSN 2572-3030
Research interests
- Colon Cancer Pancreatic Cancer Biomarkers Of Cancer Drug Resistance Molecular Therapies Of Cancer Drug Design
Biography
https://scholar.google.com/citations?user=tH5KeUEAAAAJ&hl=en
Selected publications
- In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6) 2020 cited 41×
- Molecular alterations contributing to pancreatic cancer chemoresistance 2017 cited 40×
- Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAFV600E mutation as biomarkers for papillary thyroid carcinoma 2020 cited 26×
- Oncolytic herpes simplex virus type-1 expressing IL-12 efficiently replicates and kills human colorectal cancer cells 2021 cited 25×
- Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathway 2020 cited 16×
- Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study 2022 cited 16×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCGB for your work?
This journal is guided by Dr. Ladan Teimoori-Toolabi (Molecular Medicine Department, Pasteur Institute of Iran) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.